https://www.prnewswire.com/news-releases/fda-approved-utidelone-injectable-utd1-phase-23-multi-national-clinical-trial-for-non-small-cell-lung-cancer-301851826.html
/PRNewswire/ -- Biostar Pharma, Inc. (hereinafter referred to as "Biostar"), the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a...
fda approvedutideloneinjectablephasemulti